Security
iRhythm Holdings, Inc. Common Stock · IRTC
IRTCNASDAQCommon stockCurrentCIK 1388658Updated Nov 14, 2026
Name history
IRhythm Technologies, Inc. · through Jan 12, 2026iRhythm Technologies, Inc. · through Jan 12, 2026IRhythm Technologies Inc · through May 18, 2010
IRTC price & chart
Loading TradingView…
NASDAQ:IRTC on TradingView ↗About the company
Inc. iRhythm is a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm's vision is to deliver better data, better insights, and better health for all. For more information, visit www.irhythmtech.com.
In the news
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm ↗
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm ↗
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? ↗
Recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
SCHEDULE 13G/A - filed by MILLENNIUM MANAGEMENT LLC regarding iRhythm Holdings, Inc.
Show 5 more recent filings
Regulation FD Disclosure
Items 7.01, 9.01
Regulation FD Disclosure
Items 7.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
10-Q filing
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities
Items 1.01, 3.02, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 995,214,000Source | 909,688,000Source | 1,093,426,000Source | 964,030,000Source | 919,185,000Source | 1,006,365,000Source | 926,098,000Source | 909,755,000Source | 1,020,042,000Source | 931,449,000Source | 433,144,000Source | 448,222,000Source |
| Property, Plant and Equipment, NetUSD | 149,316,000Source | 122,390,000Source | 165,308,000Source | 139,703,000Source | 117,572,000Source | 156,704,000Source | 130,850,000Source | 112,274,000Source | 151,599,000Source | 125,092,000Source | 104,114,000Source | 75,670,000Source |
| GoodwillUSD | 862,000Source | 862,000Source | 862,000Source | 862,000Source | 862,000Source | 862,000Source | 862,000Source | 862,000Source | 862,000Source | 862,000Source | 862,000Source | 862,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 255,605,000Source | 519,535,000Source | 246,679,000Source | 309,105,000Source | 550,552,000Source | 240,146,000Source | 375,278,000Source | 520,421,000Source | 236,012,000Source | 419,597,000Source | 36,173,000Source | 78,832,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 76,157,000Source | 77,427,000Source | 84,274,000Source | 82,153,000Source | 85,513,000Source | 80,863,000Source | 80,639,000Source | 89,712,000Source | 75,706,000Source | 79,941,000Source | 61,484,000Source | 49,918,000Source |
| Inventory, NetUSD | 19,559,000Source | 15,032,000Source | 22,513,000Source | 18,399,000Source | 15,425,000Source | 23,800,000Source | 14,336,000Source | 14,873,000Source | 21,634,000Source | 14,039,000Source | 13,973,000Source | 15,155,000Source |
| Assets, CurrentUSD | 680,035,000Source | 627,909,000Source | 755,954,000Source | 663,917,000Source | 677,508,000Source | 680,558,000Source | 636,013,000Source | 687,455,000Source | 702,765,000Source | 645,819,000Source | 230,812,000Source | 288,772,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 19,106,000Source | 13,419,000Source | 57,893,000Source | 17,825,000Source | 15,113,000Source | 26,275,000Source | 20,449,000Source | 13,778,000Source | 21,662,000Source | 16,286,000Source | 21,591,000Source | 10,555,000Source |
| Operating Lease, Right-of-Use AssetUSD | 43,300,000Source | 45,570,000Source | 38,794,000Source | 44,749,000Source | 46,833,000Source | 40,324,000Source | 46,171,000Source | 48,073,000Source | 41,827,000Source | 47,564,000Source | 49,317,000Source | 60,666,000Source |
| Other Assets, NoncurrentUSD | 45,252,000Source | 45,540,000Source | 50,468,000Source | 41,544,000Source | 68,052,000Source | 46,699,000Source | 41,099,000Source | 52,733,000Source | 44,718,000Source | 41,852,000Source | 48,039,000Source | 22,252,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 873,321,000Source | 837,922,000Source | 907,443,000Source | 860,370,000Source | 819,996,000Source | 845,155,000Source | 839,433,000Source | 819,465,000Source | 867,296,000Source | 840,541,000Source | 223,047,000Source | 208,410,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 32,000Source | 31,000Source | 33,000Source | 32,000Source | 31,000Source | 33,000Source | 32,000Source | 31,000Source | 32,000Source | 31,000Source | 31,000Source | 28,000Source |
| Retained Earnings (Accumulated Deficit)USD | -809,025,000Source | -757,562,000Source | -817,760,000Source | -803,813,000Source | -711,380,000Source | -817,379,000Source | -789,595,000Source | -691,273,000Source | -803,446,000Source | -758,895,000Source | -645,606,000Source | -522,200,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 285,000Source | -66,000Source | -188,000Source | -26,000Source | 182,000Source | 42,000Source | 143,000Source | -89,000Source | 403,000Source | 165,000Source | -112,000Source | -396,000Source |
| Stockholders' Equity Attributable to ParentUSD | 121,893,000Source | 71,766,000Source | 185,983,000Source | 103,660,000Source | 99,189,000Source | 161,210,000Source | 86,665,000Source | 90,290,000Source | 152,746,000Source | 90,908,000Source | 210,097,000Source | 239,812,000Source |
| Additional Paid in Capital, Common StockUSD | 955,601,000Source | 854,363,000Source | 1,028,898,000Source | 932,467,000Source | 835,356,000Source | 1,003,514,000Source | 901,085,000Source | 806,621,000Source | 980,757,000Source | 874,607,000Source | 855,784,000Source | 762,380,000Source |
| Liabilities and EquityUSD | 995,214,000Source | 909,688,000Source | 1,093,426,000Source | 964,030,000Source | 919,185,000Source | 1,006,365,000Source | 926,098,000Source | 909,755,000Source | 1,020,042,000Source | 931,449,000Source | 433,144,000Source | 448,222,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 146,910,000Source | 100,104,000Source | 196,098,000Source | 132,211,000Source | 97,895,000Source | 131,750,000Source | 111,344,000Source | 96,841,000Source | 151,890,000Source | 110,920,000Source | 107,370,000Source | 89,096,000Source |
| Operating Lease, Liability, CurrentUSD | 16,526,000Source | 15,522,000Source | 16,912,000Source | 16,360,000Source | 15,384,000Source | 16,793,000Source | 16,140,000Source | 15,289,000Source | 16,686,000Source | 15,867,000Source | 15,159,000Source | 13,031,000Source |
| Accounts Payable, CurrentUSD | 8,278,000Source | 7,593,000Source | 17,411,000Source | 12,775,000Source | 13,425,000Source | 8,559,000Source | 11,946,000Source | 8,440,000Source | 2,256,000Source | 7,221,000Source | 5,543,000Source | 7,517,000Source |
| Operating Lease, Liability, NoncurrentUSD | 67,732,000Source | 74,019,000Source | 59,341,000Source | 70,377,000Source | 76,184,000Source | 62,185,000Source | 72,125,000Source | 77,640,000Source | 64,994,000Source | 74,599,000Source | 79,715,000Source | 83,072,000Source |
| Other Liabilities, NoncurrentUSD | 9,926,000Source | 17,978,000Source | 908,000Source | 9,775,000Source | 940,000Source | 907,000Source | 8,727,000Source | 908,000Source | 908,000Source | 8,579,000Source | 1,012,000Source | 1,307,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 117,882,000Source | 73,958,000Source | 157,570,000Source | 99,577,000Source | 65,940,000Source | 102,342,000Source | 79,976,000Source | 70,044,000Source | 128,747,000Source | 84,900,000Source | 83,362,000Source | 65,497,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 472,073,000Source | 165,463,000Source | 495,356,000Source | 450,875,000Source | 75,806,000Source | 455,243,000Source | 320,256,000Source | 77,460,000Source | 490,174,000Source | 317,178,000Source | 110,185,000Source | 158,575,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 21,778,000Source | 12,094,000Source | 12,005,000Source | 24,133,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | — | — | — | — | — | — | — | — | 34,950,000Source | 34,935,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -13,933,000Source | -30,700,000Source | -44,551,000Source | -113,289,000Source | -123,406,000Source | -116,155,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 5,200,000Source | 5,100,000Source | 5,200,000Source | 5,100,000Source | 5,000,000Source | 5,200,000Source | 20,700,000Source | 20,700,000Source | 16,300,000Source | 13,400,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 21,491,000Source | 23,344,000Source | 88,283,000Source | 75,978,000Source | 77,204,000Source | 57,740,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 33,000,000Source | 30,125,000Source | 95,431,000Source | 91,920,000Source | 81,193,000Source | 61,837,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 2,424,000Source | 388,000Source | 8,512,000Source | 224,000Source | -979,000Source | 5,108,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -22,522,000Source | -489,000Source | 28,044,000Source | -7,408,000Source | -1,973,000Source | -2,993,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 118,000Source | -127,000Source | 0Source | -2,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -26,173,000Source | -7,891,000Source | 80,863,000Source | 3,390,000Source | -50,101,000Source | -23,012,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 30,215,000Source | -38,139,000Source | -277,056,000Source | -122,983,000Source | -1,209,000Source | -52,434,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 6,905,000Source | 9,419,000Source | 46,342,000Source | 33,942,000Source | 40,424,000Source | 29,830,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 0Source |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | 0Source | 0Source | 25,000,000Source | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 149,000Source | 1,729,000Source | 12,607,000Source | 511,381,000Source | 8,820,000Source | 26,716,000Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 21,389,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 4,134,000Source | -44,319,000Source | -183,585,000Source | 391,782,000Source | -42,659,000Source | -48,730,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 263,963,000Source | 527,893,000Source | 255,037,000Source | 317,463,000Source | 248,504,000Source | 383,636,000Source | 244,370,000Source | 427,955,000Source | 36,173,000Source | 78,832,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 4,959,000Source | 4,959,000Source | 9,919,000Source | 6,389,000Source | 2,960,000Source | 3,317,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | -90,000Source | 390,000Source | 1,196,000Source | 923,000Source | 1,130,000Source | 287,000Source |
| Additional Financial Items | ||||||||||||
| AmortizationUSD | — | — | 700,000Source | 900,000Source | 700,000Source | 600,000Source | 800,000Source | 600,000Source | 2,600,000Source | 2,700,000Source | — | — |
| Share-based Payment Arrangement, ExpenseUSD | — | — | 21,006,000Source | 17,158,000Source | 20,039,000Source | 22,827,000Source | 21,491,000Source | 23,344,000Source | 88,283,000Source | 75,978,000Source | 77,204,000Source | 57,740,000Source |
| AssetAcquisitionContingentConsiderationLiabilityUSD | — | — | — | — | 21,002,000Source | — | — | — | 20,407,000Source | — | — | — |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | 472,073,000Source | 165,463,000Source | 495,356,000Source | 450,875,000Source | 455,243,000Source | 320,256,000Source | 490,174,000Source | 317,178,000Source | 110,185,000Source | 158,575,000Source |
| Equity Securities, FV-NI, Gain (Loss)USD | — | — | — | — | — | — | 1,447,000Source | 843,000Source | 5,711,000Source | 1,902,000Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | 0Source | 0Source | — | 0Source | — | 0Source | 0Source | -7,589,000Source | — | — |
| GoodwillUSD | — | — | 862,000Source | 862,000Source | 862,000Source | 862,000Source | 862,000Source | 862,000Source | 862,000Source | 862,000Source | 862,000Source | 862,000Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | — | — | — | — | — | — | — | 600,000Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | 24,000Source | 188,000Source | 0Source | -183,000Source | 500,000Source | 665,000Source | 953,000Source | 565,000Source | 750,000Source | 269,000Source |
| InterestExpenseNonoperatingUSD | — | — | 3,281,000Source | 3,329,000Source | 3,294,000Source | 3,278,000Source | 3,290,000Source | 3,273,000Source | 13,154,000Source | 12,821,000Source | — | — |
| Investment Income, InterestUSD | — | — | 5,944,000Source | 6,456,000Source | 4,776,000Source | 5,321,000Source | 4,879,000Source | 4,919,000Source | 21,521,000Source | 21,938,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -5,212,000Source | -46,182,000Source | -381,000Source | -14,218,000Source | -13,933,000Source | -30,700,000Source | -44,551,000Source | -113,289,000Source | -123,406,000Source | -116,155,000Source |
| Nonoperating Income (Expense)USD | — | — | 3,241,000Source | 4,309,000Source | 2,161,000Source | 4,307,000Source | 2,752,000Source | 2,521,000Source | 13,809,000Source | 2,781,000Source | — | — |
| Operating ExpensesUSD | — | — | 145,551,000Source | 151,779,000Source | 165,747,000Source | 151,565,000Source | 157,538,000Source | 141,772,000Source | 584,657,000Source | 523,036,000Source | 456,967,000Source | 395,416,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 578,000Source | 1,182,000Source | 679,000Source | 2,264,000Source | 1,163,000Source | 875,000Source | 5,442,000Source | 1,253,000Source | 6,155,000Source | 2,036,000Source |
| Payments of Financing CostsUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 77,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Restructuring Costs and Asset Impairment ChargesUSD | — | — | — | — | — | — | — | — | — | 641,000Source | 11,078,000Source | 26,608,000Source |
| Depreciation, Depletion and Amortization, Nonproduction | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 192,884,000Source | 147,538,000Source | 224,172,000Source | 186,687,000Source | 199,390,000Source | 158,677,000Source | 747,138,000Source | 591,839,000Source | 492,681,000Source | 410,921,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Selling, General and Administrative ExpenseUSD | — | — | 124,216,000Source | 103,375,000Source | 131,655,000Source | 126,376,000Source | 135,884,000Source | 119,957,000Source | 492,553,000Source | 418,565,000Source | 385,645,000Source | 322,198,000Source |
| Operating Income (Loss)USD | — | — | -8,429,000Source | -50,303,000Source | -2,542,000Source | -18,708,000Source | -16,185,000Source | -32,556,000Source | -57,407,000Source | -115,505,000Source | -125,161,000Source | -113,784,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 578,000Source | 1,182,000Source | 679,000Source | 2,264,000Source | 1,163,000Source | 875,000Source | 5,442,000Source | 1,253,000Source | 6,155,000Source | 2,036,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -5,188,000Source | -45,994,000Source | -381,000Source | -14,401,000Source | -13,433,000Source | -30,035,000Source | -43,598,000Source | -112,724,000Source | -122,656,000Source | -115,886,000Source |
| Income Tax Expense (Benefit)USD | — | — | 24,000Source | 188,000Source | 0Source | -183,000Source | 500,000Source | 665,000Source | 953,000Source | 565,000Source | 750,000Source | 269,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -5,212,000Source | -46,182,000Source | -381,000Source | -14,218,000Source | -13,933,000Source | -30,700,000Source | -44,551,000Source | -113,289,000Source | -123,406,000Source | -116,155,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.16Source | -1.48Source | -0.01Source | -0.44Source | -0.43Source | -0.97Source | -1.39Source | -3.63Source | -4.04Source | -3.88Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.16Source | -1.48Source | -0.01Source | -0.44Source | -0.43Source | -0.97Source | -1.39Source | -3.63Source | -4.04Source | -3.88Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 32,170,000Source | 31,262,000Source | 32,895,000Source | 31,990,000Source | 32,507,000Source | 31,590,000Source | 32,004,000Source | 31,196,000Source | 30,528,000Source | 29,915,720Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 32,170,000Source | 31,262,000Source | 32,895,000Source | 31,990,000Source | 32,507,000Source | 31,590,000Source | 32,004,000Source | 31,196,000Source | 30,528,000Source | 29,915,720Source |
| Interest Expense (non-operating)USD | — | — | 3,281,000Source | 3,329,000Source | 3,294,000Source | 3,278,000Source | 3,290,000Source | 3,273,000Source | 13,154,000Source | 12,821,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 835,000Source | 692,000Source | 750,000Source | 271,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | 5,042,000Source | 5,210,000Source | 20,742,000Source | 20,715,000Source | 16,348,000Source | 13,405,000Source |
| Gross ProfitUSD | — | — | 137,122,000Source | 101,476,000Source | 163,205,000Source | 132,857,000Source | 141,353,000Source | 109,216,000Source | 527,250,000Source | 407,531,000Source | 331,806,000Source | 281,632,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -45,602,000Source | -114,203,000Source | -122,974,000Source | — |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 3,650,000Source | 4,138,000Source |
| Interest Expense, DebtUSD | — | — | 3,281,000Source | 3,273,000Source | 3,294,000Source | 3,278,000Source | 3,289,000Source | 3,273,000Source | — | — | 3,400,000Source | — |
| Investment Income, InterestUSD | — | — | 5,944,000Source | 6,456,000Source | 4,776,000Source | 5,321,000Source | 4,879,000Source | 4,919,000Source | 21,521,000Source | 21,938,000Source | — | — |
| Nonoperating Income (Expense)USD | — | — | 3,241,000Source | 4,309,000Source | 2,161,000Source | 4,307,000Source | 2,752,000Source | 2,521,000Source | 13,809,000Source | 2,781,000Source | — | — |
| Operating ExpensesUSD | — | — | 145,551,000Source | 151,779,000Source | 165,747,000Source | 151,565,000Source | 157,538,000Source | 141,772,000Source | 584,657,000Source | 523,036,000Source | 456,967,000Source | 395,416,000Source |
| Research and Development ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 60,244,000Source | 46,610,000Source |
Filing attachments
tm2629543d1_ex99-1.htm · 8-K · 2026-11-12
Exhibit 99.1 iRhythm Announces Approval of $200 Million Share Repurchase Program SAN FRANCISCO, November 11, 2026 - iRhythm Holdings, Inc. (Nasdaq: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease, today announced that on November 10, 2026, its Board of Directors approved a share repurchase program with authorization to purchase up to $200 million of the company’s outstanding common stock. The approval reflects i…
Read attachment ↗tm262849d1_ex4-1.htm · 8-K12B · 2026-01-12
Exhibit 4.1 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 iRhythm Holdings, Inc. (the “Company”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock, par value $0.0001 per share. As used in this summary, the terms “iRhythm,” “the Company,” “we,” “our” and “us” refer to iRhythm Holdings, Inc. The following is a description of the material terms and pro…
Read attachment ↗tm262849d1_ex4-2.htm · 8-K12B · 2026-01-12
Exhibit 4.2 ____________________________________________ IRHYTHM TECHNOLOGIES, INC., AS COMPANY, IRHYTHM HOLDINGS, INC., AS GUARANTOR, and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS TRUSTEE ____________________________________________ First Supplemental Indenture Dated as of January 12, 2026 to the Indenture Dated as of March 7, 2024 ____________________________________________ FIRST SUPPLEMENTAL INDENTURE This FIRST SUPPLEMENTAL INDENTURE (this “First Supplemental Indent…
Read attachment ↗tm262849d1_ex99-1.htm · 8-K12B · 2026-01-12
Exhibit 99.1 iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44 th Annual J.P. Morgan Healthcare Conference SAN FRANCISCO, JANUARY 12, 2026 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 44th Annual J.P. Morgan He…
Read attachment ↗tm262849d1_ex99-2.htm · 8-K12B · 2026-01-12
Exhibit 99.2 © 2026 iRhythm Technologies, Inc. 1 iRhythm at the J.P. Morgan 44th Annual Healthcare Conference Quentin Blackford, President & Chief Executive Officer January 12, 2026 ────────────────────────────────────────────────────────── 2 © 2026 iRhythm Technologies, Inc. 2 Cautionary statement re forward-looking statements, non-GAAP measures and other matters Certain data in this presentation was obtained from various external sources, and neither “iRhythm Technologie…
Read attachment ↗